Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 101–200 of 1,013
Diekman, B. O., Rowland, C. R., Lennon, D. P., Caplan, A. I., & Guilak, F. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0398 · Cited by 267
“Some differences include ASCs being smaller,(16) ASCs achieving higher passage numbers before senescence,(15,23,26) differential expression of genes related to proliferation,(26,32) and ASCs having reduced or absent transforming growth factor b (TGF-b) receptor ALK-5(21) and cell surface marker vascular cell adhesion…”
Heterogeneity of mesenchymal stromal cell preparations
Ho, A. D., Wagner, W., & Franke, W. (2008) · Cytotherapy · doi:10.1080/14653240802217011 · Cited by 266
Mesenchymal stem cells for clinical application
Sensebé, L., Krampera, M., Schrezenmeier, H., Bourin, P., & Giordano, R. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2009.01227.x · Cited by 258
Mesenchymal Stem Cell Preparations—Comparing Apples and Oranges
Wagner, W., & Ho, A. D. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-9001-1 · Cited by 263
“potentials and functional implications varied widely among MSC preparations derived from different origins [27, 41].”
BackgroundNative human adipose stromal cells: localization, morphology and phenotype
Maumus, M., Peyrafitte, J.-A., D'Angelo, R., Fournier-Wirth, C., Bouloumié, A., Casteilla, L., Sengenès, C., & Bourin, P. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.269 · Cited by 262
Liu, Y., Zhu, Z., Pei, X., Zhang, X., Cheng, X., Hu, S., Gao, X., Wang, J., Chen, J., & Wan, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12090 · Cited by 259
MSCs: Biological characteristics, clinical applications and their outstanding concerns
Si, Y.-L., Zhao, Y.-L., Hao, H.-J., Fu, X.-B., & Han, W.-D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.005 · Cited by 259
Taléns-Visconti, R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i36.5834 · Cited by 253
Human adipose‐derived stem cells: isolation, characterization and applications in surgery
Locke, M., Windsor, J., & Dunbar, P. R. (2009) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2009.04852.x · Cited by 254
Chang, Y. S., Oh, W., Choi, S. J., Sung, D. K., Kim, S. Y., Choi, E. Y., Kang, S., Jin, H. J., Yang, Y. S., & Park, W. S. (2009) · Cell Transplantation · doi:10.3727/096368909x471189 · Cited by 254
Isolation of mesenchymal stem cells from equine umbilical cord blood
Koch, T. G., Heerkens, T., Thomsen, P. D., & Betts, D. H. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-26 · Cited by 240
Orbay, H., Tobita, M., & Mizuno, H. (2012) · Stem Cells International · doi:10.1155/2012/461718 · Cited by 250
“Despite the vast variety of source tissues, MSCs show some common characteristics that support the hypothesis of a common origin [1, 18].”
Background3D bioprinting of BM-MSCs-loaded ECM biomimetic hydrogels for in vitro neocartilage formation
Costantini, M., Idaszek, J., Szöke, K., Jaroszewicz, J., Dentini, M., Barbetta, A., Brinchmann, J. E., & Święszkowski, W. (2016) · Biofabrication · doi:10.1088/1758-5090/8/3/035002 · Cited by 250
Osteogenic Differentiation of Noncultured Immunoisolated Bone Marrow‐Derived CD105 + Cells
Aslan, H., Zilberman, Y., Kandel, L., Liebergall, M., Oskouian, R. J., Gazit, D., & Gazit, Z. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0546 · Cited by 236
Zhang, X., Hirai, M., Cantero, S., Ciubotariu, R., Dobrila, L., Hirsh, A., Igura, K., Satoh, H., Yokomi, I., Nishimura, T., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23042 · Cited by 248
“DLK-1 is a pre-adipocyte factor, and was proposed to be a specific marker for USSC [Kluth et al., 2010].”
BackgroundThe role of mesenchymal stem cells in maintenance and repair of bone
Bielby, R., Jones, E., & McGonagle, D. (2007) · Injury · doi:10.1016/j.injury.2007.02.007 · Cited by 236
Grisendi, G., Bussolari, R., Cafarelli, L., Petak, I., Rasini, V., Veronesi, E., De Santis, G., Spano, C., Tagliazzucchi, M., Barti-Juhasz, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1865 · Cited by 245
Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation
Jo, H., Brito, S., Kwak, B. M., Park, S., Lee, M.-G., & Bin, B.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052410 · Cited by 230
“05% of adipose tissue from a donor can be used as a source of MSCs [127,128].”
BackgroundGood Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells
Sensebé, L., Bourin, P., & Tarte, K. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.197 · Cited by 233
“The main candidates for clinical application are BM, AT, and cord blood (Kern et al. , 2006).”
Adipose-Derived Stem Cells and Their Secretory Factors as a Promising Therapy for Skin Aging
PARK, B.-S., JANG, K. A., SUNG, J.-H., PARK, J.-S., KWON, Y. H., KIM, K. J., & KIM, W.-S. (2008) · Dermatologic Surgery · doi:10.1097/00042728-200810000-00003 · Cited by 240
“In addition, compared with bone marrow–derived mesenchymal stem cells, ADSCs can be acquired in large quantities with a simple surgical procedure.(2) There have been many clinical applications for mesenchymal stem cells, including ADSCs for compensation of skin defects and wound healing.”
BackgroundEffects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Lavrentieva, A., Majore, I., Kasper, C., & Hass, R. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-18 · Cited by 241
“Thus, human MSC isolated from bone marrow (BM), adipose tissues or other sources are of great interest for tissue engineering and tissue replacement, since these cell populations are characterized by a high proliferative activity, self-renewal capacity, low immunogenicity and the potential to differentiate along the m…”
BackgroundHuman mesenchymal stem cells isolated from the umbilical cord
Qiao, C., Xu, W., Zhu, W., Hu, J., Qian, H., Yin, Q., Jiang, R., Yan, Y., Mao, F., Yang, H., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2007.08.002 · Cited by 241
Galderisi, U., Peluso, G., & Di Bernardo, G. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10231-w · Cited by 240
Petrenko, Y., Vackova, I., Kekulova, K., Chudickova, M., Koci, Z., Turnovcova, K., Kupcova Skalnikova, H., Vodicka, P., & Kubinova, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-61167-z · Cited by 218
Mebarki, M., Abadie, C., Larghero, J., & Cras, A. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02222-y · Cited by 223
“While UC-MSCs frequency is around 10% versus 10 to 10% for BM-MSCs [4, 5], they display higher proliferation capacities.”
BackgroundInfluentialNeuronal Differentiation Potential of Human Adipose-Derived Mesenchymal Stem Cells
Anghileri, E., Marconi, S., Pignatelli, A., Cifelli, P., Galié, M., Sbarbati, A., Krampera, M., Belluzzi, O., & Bonetti, B. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0197 · Cited by 232
“Adipose-derived MSC (A-MSC) may represent a valid alternative to BM-MSC, because of their pluripotency and ability to differentiate in mesenchymal and non-mesenchymal lineages; moreover, they are readily accessible and quickly proliferate in vitro, with lower senescence ratio than BM-MSC.”
InfluentialAdipose-derived stromal cells: their identity and uses in clinical trials, an update
Casteilla, L. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i4.25 · Cited by 235
The Effect of Hypoxia on Mesenchymal Stem Cell Biology
Ejtehadifar, M., Shamsasenjan, K., Movassaghpour, A., Akbarzadehlaleh, P., Dehdilani, N., Abbasi, P., Molaeipour, Z., & Saleh, M. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.021 · Cited by 235
Bioreactor Systems for Bone Tissue Engineering
Rauh, J., Milan, F., Günther, K.-P., & Stiehler, M. (2011) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2010.0612 · Cited by 225
“MSCs are mostly isolated from bone marrow aspirates, but can also be obtained from other tissues, for example, adipose tissue or cord blood.(16) MSCs have the potential to differentiate toward diverse mesenchymal lineages, including osteoblasts, chondrocytes, adipocytes, and myocytes.”
Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells
Liao, H.-T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i3.288 · Cited by 229
Retinal stem cell transplantation: Balancing safety and potential
Singh, M. S., Park, S. S., Albini, T. A., Canto-Soler, M. V., Klassen, H., MacLaren, R. E., Takahashi, M., Nagiel, A., Schwartz, S. D., & Bharti, K. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100779 · Cited by 225
“(Hankin and Lund, 1987; Kirschen McLoon et al., 1981).”
Diabetes impairs adipose tissue–derived stem cell function and efficiency in promoting wound healing
Cianfarani, F., Toietta, G., Di Rocco, G., Cesareo, E., Zambruno, G., & Odorisio, T. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12051 · Cited by 226
Crespo-Diaz, R., Behfar, A., Butler, G. W., Padley, D. J., Sarr, M. G., Bartunek, J., Dietz, A. B., & Terzic, A. (2011) · Cell Transplantation · doi:10.3727/096368910x543376 · Cited by 233
Wagner, W., Roderburg, C., Wein, F., Diehlmann, A., Frankhauser, M., Schubert, R., Eckstein, V., & Ho, A. D. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0280 · Cited by 220
Immunosuppression by mesenchymal stromal cells: From culture to clinic
Jones, B. J., & McTaggart, S. J. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.03.006 · Cited by 227
Shin, S., Lee, J., Kwon, Y., Park, K.-S., Jeong, J.-H., Choi, S.-J., Bang, S. I., Chang, J. W., & Lee, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020845 · Cited by 208
Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin
Wegmeyer, H., Bröske, A.-M., Leddin, M., Kuentzer, K., Nisslbeck, A. K., Hupfeld, J., Wiechmann, K., Kuhlen, J., von Schwerin, C., Stein, C., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0016 · Cited by 218
The Influence of Aging on the Regenerative Potential of Human Adipose Derived Mesenchymal Stem Cells
Marędziak, M., Marycz, K., Tomaszewski, K. A., Kornicka, K., & Henry, B. M. (2016) · Stem Cells International · doi:10.1155/2016/2152435 · Cited by 225
“However, the most common and effective way of acquiring the cells is from adipose tissue [14, 15].”
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
Porada, C. D., & Almeida-Porada, G. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.010 · Cited by 223
Mesenchymal Stem Cell Delivery Routes and Fate
Kurtz, A. (2008) · International Journal of Stem Cells · doi:10.15283/ijsc.2008.1.1.1 · Cited by 218
Tipnis, S., Viswanathan, C., & Majumdar, A. S. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2010.47 · Cited by 218
Mesenchymal stromal cell therapy for liver diseases
Alfaifi, M., Eom, Y. W., Newsome, P. N., & Baik, S. K. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.030 · Cited by 217
“6 MSC from differing sources such as AT, UCB, and BM were found to express a similar pattern of surface antigens [31], although there was variation in respect to their differentiation potential, morphology and proliferation rate [32].”
BackgroundSecunda, R., Vennila, R., Mohanashankar, A. M., Rajasundari, M., Jeswanth, S., & Surendran, R. (2015) · Cytotechnology · doi:10.1007/s10616-014-9718-z · Cited by 205
“Improvement of liver function was also observed after injection of autologous MSC in liver cirrhosis patients during phase I–II clinical trial (Kharaziha et al. 2009).”
BackgroundMesenchymal Stem Cells for Chronic Wound Healing: Current Status of Preclinical and Clinical Studies
Huang, Y.-Z., Gou, M., Da, L.-C., Zhang, W.-Q., & Xie, H.-Q. (2020) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0351 · Cited by 209
“45 The Critical Roles of MSCs in Wound Healing The mechanisms of MSC-based wound therapy have not been fully delineated, yet, two mechanisms are generally postulated: (i) direct differentiation into skin cells and (ii) the secretion of trophic factors (Fig.”
Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model
Sun, B., Roh, K.-H., Park, J.-R., Lee, S.-R., Park, S.-B., Jung, J.-W., Kang, S.-K., Lee, Y.-S., & Kang, K.-S. (2009) · Cytotherapy · doi:10.1080/14653240902807026 · Cited by 214
Pettine, K. A., Murphy, M. B., Suzuki, R. K., & Sand, T. T. (2015) · Stem Cells · doi:10.1002/stem.1845 · Cited by 201
Chen, Y. S., Pelekanos, R. A., Ellis, R. L., Horne, R., Wolvetang, E. J., & Fisk, N. M. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0022 · Cited by 216
Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial
Gjerde, C., Mustafa, K., Hellem, S., Rojewski, M., Gjengedal, H., Yassin, M. A., Feng, X., Skaale, S., Berge, T., Rosen, A., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0951-9 · Cited by 200
Tan, Q., Lui, P. P. Y., Rui, Y. F., & Wong, Y. M. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0362 · Cited by 207
“Kern et al.(24) has done a comparative analysis of MSC from bone marrow, umbilical cord blood, and adipose tissue.”
BackgroundInfluentialMagatti, M., De Munari, S., Vertua, E., Gibelli, L., Wengler, G. S., & Parolini, O. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0491 · Cited by 208
“Furthermore, our findings may help to reconcile the current debate both on the presence of HLA-DR cells, which remains a controversial issue in MSC in general [ 13 , 23, 60, 62], and also the paradoxical results that have been obtained after transplantation of BM-MSC.”
BackgroundInfluential“Humanized” Stem Cell Culture Techniques: The Animal Serum Controversy
Tekkatte, C., Gunasingh, G. P., Cherian, K. M., & Sankaranarayanan, K. (2011) · Stem Cells International · doi:10.4061/2011/504723 · Cited by 199
“The variations in the hMSC differentiation and surfacemarker expression due to differences in their in vivo stem cell niche [105, 106] may also affect the reproducibility of the optimum medium conditions identified.”
BackgroundZhou, W., Lin, J., Zhao, K., Jin, K., He, Q., Hu, Y., Feng, G., Cai, Y., Xia, C., Liu, H., et al. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546519848678 · Cited by 200
McKay Orthopaedic Research Laboratory, U. O. P., McLeod, C., & Mauck, R. (2017) · European Cells and Materials · doi:10.22203/ecm.v034a14 · Cited by 197
“Tissue-dependent variation in differentiation capacity, surface markers and transcriptional and proteomic profiles is widely studied, and the reader is referred to recent reviews for comparisons of MSCs across tissue sources (Kern et al., 2006; Mattar and Bieback, 2015; Strioga et al., 2012).”
Wu, M., Zhang, R., Zou, Q., Chen, Y., Zhou, M., Li, X., Ran, R., & Chen, Q. (2018) · Scientific Reports · doi:10.1038/s41598-018-23396-1 · Cited by 206
Secretory Profiles and Wound Healing Effects of Human Amniotic Fluid–Derived Mesenchymal Stem Cells
Yoon, B. S., Moon, J.-H., Jun, E. K., Kim, J., Maeng, I., Kim, J. S., Lee, J. H., Baik, C. S., Kim, A., Cho, K. S., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0138 · Cited by 203
“To examine whether the AF-MSCs could differentiate into adipocytes, the AF-MSCs and BM-MSCs (used as comparative control for this study) were subjected to 3 cycles of culture in adipogenic induction and maintenance media (AS + ) or control media (AS–) [26,27].”
InfluentialPrzekora, A. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.061 · Cited by 200
Tissue engineering strategies for promoting vascularized bone regeneration
Almubarak, S., Nethercott, H., Freeberg, M., Beaudon, C., Jha, A., Jackson, W., Marcucio, R., Miclau, T., Healy, K., & Bahney, C. (2016) · Bone · doi:10.1016/j.bone.2015.11.011 · Cited by 199
Marconi, S., Castiglione, G., Turano, E., Bissolotti, G., Angiari, S., Farinazzo, A., Constantin, G., Bedogni, G., Bedogni, A., & Bonetti, B. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0491 · Cited by 199
“The comparative analysis of ASC and BM-MSC clearly showed that both populations shared a common morphology, immune phenotype, success rate of isolation, colony frequency, and differentiation potential.(13,14) With regard to the cell surface marker expression, ASC showed a peculiar adhesion molecules profile with the e…”
Singh, A., Singh, A., & Sen, D. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0341-0 · Cited by 192
“The colony frequency of cells obtained from adipose tissue is higher than those of bone marrow [125] and cord blood, and these adipose tissue-derived MSCs (ASCs) can differentiate into adipocytes, chondrocytes and osteoblasts [125].”
BackgroundMesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential
Volarevic, V., Gazdic, M., Simovic Markovic, B., Jovicic, N., Djonov, V., & Arsenijevic, N. (2017) · BioFactors · doi:10.1002/biof.1374 · Cited by 195
“In contrast to BM-MSCs and AT-MSCs, UCBMSCs have the highest rates of cell proliferation and clonality and significantly lower expression of p53, p21, and p16, well known markers of senescence [9,10].”
BackgroundAdvances in regenerative therapy: A review of the literature and future directions
Ntege, E. H., Sunami, H., & Shimizu, Y. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.01.004 · Cited by 194
Ex Vivo Expansion of Human Mesenchymal Stem Cells in Defined Serum-Free Media
Jung, S., Panchalingam, K. M., Rosenberg, L., & Behie, L. A. (2012) · Stem Cells International · doi:10.1155/2012/123030 · Cited by 189
“, corresponding to hMSCs) calculated at the basis of 1 × 106 initially plated cells was highest for AT (557), followed by BM (83) [37].”
BackgroundExpression of Mineralization Markers in Dental Pulp Cells
Wei, X., Ling, J., Wu, L., Liu, L., & Xiao, Y. (2007) · Journal of Endodontics · doi:10.1016/j.joen.2007.02.009 · Cited by 197
Biological properties of mesenchymal Stem Cells from different sources.
Via, A. G., Frizziero, A., & Oliva, F. (2012) · Europe PMC (PubMed Central) · Cited by 273
Carrade, D. D., Lame, M. W., Kent, M. S., Clark, K. C., Walker, N. J., & Borjesson, D. L. (2012) · Cell Medicine · doi:10.3727/215517912x647217 · Cited by 185
Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential
Rohban, R., & Pieber, T. R. (2017) · Stem Cells International · doi:10.1155/2017/5173732 · Cited by 190
Yamada, Y., Ito, K., Nakamura, S., Ueda, M., & Nagasaka, T. (2011) · Cell Transplantation · doi:10.3727/096368910x539128 · Cited by 196
Fibroblasts and mesenchymal stem cells: Two sides of the same coin?
Soundararajan, M., & Kannan, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26860 · Cited by 190
Granéli, C., Thorfve, A., Ruetschi, U., Brisby, H., Thomsen, P., Lindahl, A., & Karlsson, C. (2014) · Stem Cell Research · doi:10.1016/j.scr.2013.09.009 · Cited by 187
Mesenchymal Stem Cells and Osteoblast Differentiation
Aubin, J. E. (2008) · Principles of Bone Biology · doi:10.1016/b978-0-12-373884-4.00026-4 · Cited by 190
The Lamina Propria of Adult Human Oral Mucosa Harbors a Novel Stem Cell Population
Marynka-Kalmani, K., Treves, S., Yafee, M., Rachima, H., Gafni, Y., Cohen, M. A., & Pitaru, S. (2010) · Stem Cells · doi:10.1002/stem.425 · Cited by 188
(2010) · Springer eBooks · doi:10.1007/978-3-540-89656-2 · Cited by 169
Hoogduijn, M. J., Crop, M. J., Peeters, A. M. A., Van Osch, G. J. V. M., Balk, A. H. M. M., Ijzermans, J. N. M., Weimar, W., & Baan, C. C. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0110 · Cited by 189
“Earlier studies have shown that MSCs are also pres-ent in human placenta, umbilical cord blood, and skin and that regardless of the tissue, these MSCs possess characteristics that are similar to a large extent to bone marrow MSCs (16,20–22).”
Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer
Cao, Y., Gang, X., Sun, C., & Wang, G. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9328347 · Cited by 183
“AMSCs have high colony frequency and represent an attractive alternative source of pluripotent cells, whose characteristics are similar to BM-MSCs [42, 74].”
BackgroundHsieh, J.-Y., Fu, Y.-S., Chang, S.-J., Tsuang, Y.-H., & Wang, H.-W. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0485 · Cited by 189
“Comparative analysis between MSCs derived from BM, umbilical cord blood, and adipose tissue has been conducted [4,14].”
Cavarretta, I. T., Altanerova, V., Matuskova, M., Kucerova, L., Culig, Z., & Altaner, C. (2010) · Molecular Therapy · doi:10.1038/mt.2009.237 · Cited by 186
Fujita, Y., Kadota, T., Araya, J., Ochiya, T., & Kuwano, K. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100355 · Cited by 188
“(i) higher yield of cells per gram of tissue, (ii) higher cell proliferation rate than BM-MSCs and (iii) easier access to the cell source because adipose tissue is often discarded after surgical procedures [32,33].”
BackgroundMechanisms of T-Cell Immunosuppression by Mesenchymal Stromal Cells: What Do We Know So Far?
Haddad, R., & Saldanha-Araujo, F. (2014) · BioMed Research International · doi:10.1155/2014/216806 · Cited by 188
Reviewing and Updating the Major Molecular Markers for Stem Cells
Calloni, R., Cordero, E. A. A., Henriques, J. A. P., & Bonatto, D. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0637 · Cited by 183
“MSCs are also found in fetal tissues and fluids, such as amniotic fluid, umbilical cord blood [117], amnion, and placenta [118].”
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
Chen, P.-M., Yen, M.-L., Liu, K.-J., Sytwu, H.-K., & Yen, B.-L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-49 · Cited by 180
“Moreover, the immunomodulatory properties of MSCs from different organs have not been much investigated, and one comparative study suggests that the MSC niche is unique in each tissue, which can contributes to functional differences [111].”
BackgroundTherapeutic Hydrogels: Properties and Biomedical Applications
Dong, S., An, S., Saiding, Q., Chen, Q., Liu, B., Kong, N., Chen, W., & Tao, W. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00182 · Cited by 195
Specification of a Dopaminergic Phenotype from Adult Human Mesenchymal Stem Cells
Trzaska, K. A., Kuzhikandathil, E. V., & Rameshwar, P. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0212 · Cited by 181
Mesenchymal stem cell differentiation and roles in regenerative medicine
Hwang, N. S., Zhang, C., Hwang, Y., & Varghese, S. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.26 · Cited by 176
Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury
Morigi, M., Rota, C., Montemurro, T., Montelatici, E., Lo Cicero, V., Imberti, B., Abbate, M., Zoja, C., Cassis, P., Longaretti, L., et al. (2010) · Stem Cells · doi:10.1002/stem.293 · Cited by 184
Niemeyer, P., Kornacker, M., Mehlhorn, A., Seckinger, A., Vohrer, J., Schmal, H., Kasten, P., Eckstein, V., Südkamp, N. P., & Krause, U. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0114 · Cited by 179
“…were compared recently and the properties of MSCs from bone marrow aspirates, adipose tissue, and umbilical cord blood were found to be similar, 10,11 the particular immunological characteristics of human BMSCs, which have been subjected to various investigations in past years, and of MSCs…”
InfluentialThe regenerative role of adipose‐derived stem cells (ADSC) in plastic and reconstructive surgery
Naderi, N., Combellack, E. J., Griffin, M., Sedaghati, T., Javed, M., Findlay, M. W., Wallace, C. G., Mosahebi, A., Butler, P. E., Seifalian, A. M., et al. (2017) · International Wound Journal · doi:10.1111/iwj.12569 · Cited by 173
Jung, K. H., Song, S. U., Yi, T., Jeon, M., Hong, S., Zheng, H., Lee, H., Choi, M., Lee, D., & Hong, S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.047 · Cited by 180
Markers of stemness in equine mesenchymal stem cells: a plea for uniformity
De Schauwer, C., Meyer, E., Van de Walle, G. R., & Van Soom, A. (2011) · Theriogenology · doi:10.1016/j.theriogenology.2010.11.008 · Cited by 177
Akimoto, K., Kimura, K., Nagano, M., Takano, S., To'a Salazar, G., Yamashita, T., & Ohneda, O. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0486 · Cited by 176
“In addition, AT-MSCs can be cultured for several months with low levels of senescence, retaining the potential to differentiate into various cell types [2].”
InfluentialEiró, N. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i3.62 · Cited by 173
Moll, G., Geißler, S., Catar, R., Ignatowicz, L., Hoogduijn, M. J., Strunk, D., Bieback, K., & Ringdén, O. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-45457-3_7 · Cited by 175
Self-citationJun, E., Zhang, Q., Yoon, B., Moon, J.-H., Lee, G., Park, G., Kang, P., Lee, J., Kim, A., & You, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010605 · Cited by 176
“AF-MSCs that were cultured in normoxic and hypoxic conditions were subjected to adipogenic differentiation [29,33].”
MethodMesenchymal Stem Cells Prevent Hydrocephalus After Severe Intraventricular Hemorrhage
Ahn, S. Y., Chang, Y. S., Sung, D. K., Sung, S. I., Yoo, H. S., Lee, J. H., Oh, W. I., & Park, W. S. (2013) · Stroke · doi:10.1161/strokeaha.112.679092 · Cited by 172
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D., & Prockop, D. J. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201012-071dw · Cited by 171
Dahl, J.-A., Duggal, S., Coulston, N., Millar, D., Melki, J., Shahdadfar, A., Brinchmann, J. E., & Collas, P. (2008) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082663jd · Cited by 171
“…(Boquest et al., 2005; Kucia et al., 2005), ASCs have a similar immunophenotype and gene expression profile to BMMSCs (Freitas and Dalmau, 2006: Kern et al., 2006), display a similar in vitro differentiation potential (Kern et al., 2006) and similar genome-wide DNA methylation profiles on…”
BackgroundKato, Y., Iwata, T., Morikawa, S., Yamato, M., Okano, T., & Uchigata, Y. (2015) · Diabetes · doi:10.2337/db14-1133 · Cited by 173
Uncovering the secretes of mesenchymal stem cells
Lavoie, J. R., & Rosu-Myles, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.017 · Cited by 176
The use of mesenchymal stem cells in tissue engineering: A global assessment
Rosenbaum, A. J., Grande, D. A., & Dines, J. S. (2008) · Organogenesis · doi:10.4161/org.6048 · Cited by 170
Protective role of adipose-derived stem cells and their soluble factors in photoaging
Kim, W.-S., Park, B.-S., & Sung, J.-H. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0951-9 · Cited by 177
“The yield of stem cells from adipose tissue is approximately 40-fold greater than that from bone marrow, and ADSCs are available in liposuction aspirate [3, 11, 13].”
Sousa, B. R., Parreira, R. C., Fonseca, E. A., Amaya, M. J., Tonelli, F. M. P., Lacerda, S. M. S. N., Lalwani, P., Santos, A. K., Gomes, K. N., Ulrich, H., et al. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22402 · Cited by 172
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.